A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsGeneration of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.Synergistic immunologic targets for the treatment of prostate cancer.The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
P2860
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@ast
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@en
type
label
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@ast
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@en
prefLabel
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@ast
A peripheral circulating TH1 c ...... ostate cancer risk in CLUE II.
@en
P2093
P2860
P1476
A peripheral circulating TH1 c ...... rostate cancer risk in CLUE II
@en
P2093
Alan K Meeker
Angelo M De Marzo
Charles G Drake
Djeneba Dabitao
Elizabeth A Platz
Nrupen A Bhavsar
Sarah B Peskoe
William B Isaacs
P2860
P304
P356
10.1158/1055-9965.EPI-14-0010
P50
P577
2014-08-22T00:00:00Z